2023 Q2 Form 10-Q Financial Statement

#000149315223022172 Filed on June 23, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q4
Revenue $4.992K $5.000K
YoY Change
Cost Of Revenue $2.621K $2.292K
YoY Change
Gross Profit $2.371K $2.708K
YoY Change
Gross Profit Margin 47.5% 54.16%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit -$2.806K -$6.808K -$4.945K
YoY Change 116.51%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$2.806K -$4.945K
YoY Change 116.51%
Income Tax
% Of Pretax Income
Net Earnings -$2.806K -$6.808K -$4.945K
YoY Change 116.51%
Net Earnings / Revenue -56.21% -136.16%
Basic Earnings Per Share $0.00 $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 3.600M shares 3.600M shares 3.600M shares
Diluted Shares Outstanding 3.600M shares 3.600M shares 3.600M shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $7.083K $12.91K $14.00K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $7.197K
Prepaid Expenses
Receivables $4.992K
Other Receivables
Total Short-Term Assets $19.27K
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $19.27K
Total Long-Term Assets $0.00
Total Assets $19.27K $22.53K $16.29K
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $9.986K
YoY Change
Accrued Expenses $6.400K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $46.81K
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $46.81K
Total Long-Term Liabilities
Total Liabilities $46.81K
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$31.13K
YoY Change
Common Stock $3.600K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$27.53K -$24.73K -$17.92K
YoY Change
Total Liabilities & Shareholders Equity $19.27K
YoY Change

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q4
OPERATING ACTIVITIES
Net Income -$2.806K -$6.808K -$4.945K
YoY Change 116.51%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$4.083K
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities -$4.083K
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash -$4.083K
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$4.083K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001935033
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--07-31
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
usd
CY2023Q2 us-gaap Other Liability Current Related Party Type Extensible Enumeration
OtherLiabilityCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/srt/2023#DirectorMember
CY2022Q3 us-gaap Other Liability Current Related Party Type Extensible Enumeration
OtherLiabilityCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/srt/2023#DirectorMember
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
usd
CY2022Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
usd
us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
usd
KFGL Increase Decrease In Subscription Receivable
IncreaseDecreaseInSubscriptionReceivable
usd
CY2022Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
usd
CY2022Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
usd
CY2022Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
usd
CY2022Q2 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
CY2022Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
CY2022Q2 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2023Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2023Q2 KFGL Capital Expenditure
CapitalExpenditure
usd
CY2023Q2 KFGL Capital Expenditure
CapitalExpenditure
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-04-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
333-267967
dei Entity Registrant Name
EntityRegistrantName
KEEMO FASHION GROUP LIMITED
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
32-0686375
dei Entity Address Address Line1
EntityAddressAddressLine1
69 Wanke Boyu
dei Entity Address Address Line2
EntityAddressAddressLine2
Xili Liuxin 1st Rd
dei Entity Address Address Line3
EntityAddressAddressLine3
Nanshan District
dei Entity Address City Or Town
EntityAddressCityOrTown
Shenzhen
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
518052
dei Entity Address Country
EntityAddressCountry
CN
dei City Area Code
CityAreaCode
+86
dei Local Phone Number
LocalPhoneNumber
176-1282-2030
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
3600000 shares
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7083 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18080 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4992 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
7197 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
2504 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
19272 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
20584 usd
CY2023Q2 us-gaap Assets
Assets
19272 usd
CY2022Q3 us-gaap Assets
Assets
20584 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
9986 usd
CY2023Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
30419 usd
CY2022Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
25758 usd
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
6400 usd
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
7800 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
46805 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
33558 usd
CY2023Q2 us-gaap Liabilities
Liabilities
46805 usd
CY2022Q3 us-gaap Liabilities
Liabilities
33558 usd
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3600000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3600000 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3600000 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3600000 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
3600 usd
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
3600 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-31133 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-16574 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-27533 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-12974 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
19272 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
20584 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4992 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9992 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
2621 usd
us-gaap Cost Of Revenue
CostOfRevenue
4913 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
2371 usd
us-gaap Gross Profit
GrossProfit
5079 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5177 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1296 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
19638 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1296 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2806 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1296 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-14559 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1296 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2806 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1296 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-14559 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1296 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-2806 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1296 usd
us-gaap Net Income Loss
NetIncomeLoss
-14559 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1296 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2806 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1296 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-14559 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1296 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3600000 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3600000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3600000 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3600000 shares
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3600 usd
us-gaap Net Income Loss
NetIncomeLoss
-16574 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-12974 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-4945 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-17919 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-6808 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-24727 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-2806 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-27533 usd
us-gaap Net Income Loss
NetIncomeLoss
-14559 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1296 usd
CY2022Q2 KFGL Increase Decrease In Subscription Receivable
IncreaseDecreaseInSubscriptionReceivable
3600 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4992 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4693 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
9986 usd
us-gaap Increase Decrease In Due To Other Related Parties
IncreaseDecreaseInDueToOtherRelatedParties
4661 usd
CY2022Q2 us-gaap Increase Decrease In Due To Other Related Parties
IncreaseDecreaseInDueToOtherRelatedParties
1296 usd
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-1400 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-10997 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3600 usd
CY2022Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3600 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3600 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-10997 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
18080 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7083 usd
us-gaap Net Income Loss
NetIncomeLoss
-14559 usd
CY2023Q2 KFGL Working Capital
WorkingCapital
27533 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-27533 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_847_eus-gaap--UseOfEstimates_zl13nWHyd84g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_867_zLDzBmFi1vS7">Use of Estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management uses estimates and assumptions in preparing these financial statements in accordance with US GAAP. Those estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities in the balance sheets, and the reported revenue and expenses during the periods reported. Actual results may differ from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-14559 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-14559 usd
us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-14559 usd
us-gaap Operating Loss Carryforwards Limitations On Use
OperatingLossCarryforwardsLimitationsOnUse
The NOL carryforwards begin to expire in 2043
CY2023Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
3057 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
7197 usd
CY2023Q2 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
9986 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6400 usd
CY2022Q2 us-gaap Common Stock Shares Subscribed But Unissued
CommonStockSharesSubscribedButUnissued
3600000 shares
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
3600 usd
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3600000 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3600000 shares
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2023Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
3057 usd
CY2023Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
3057 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9992 usd
us-gaap Cost Of Revenue
CostOfRevenue
4913 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
19638 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-14559 usd
CY2023Q2 us-gaap Assets
Assets
19272 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9992 usd
us-gaap Cost Of Revenue
CostOfRevenue
4913 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
19638 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-14559 usd
CY2023Q2 us-gaap Assets
Assets
19272 usd

Files In Submission

Name View Source Status
0001493152-23-022172-index-headers.html Edgar Link pending
0001493152-23-022172-index.html Edgar Link pending
0001493152-23-022172.txt Edgar Link pending
0001493152-23-022172-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
kfgl-20230430.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
kfgl-20230430_cal.xml Edgar Link unprocessable
kfgl-20230430_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
kfgl-20230430_def.xml Edgar Link unprocessable
kfgl-20230430_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending